돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2037379생성일: 2026년 10월 27일

Ethanesulfonamide potassium salt → Ethanesulfonic acid ((2s)-3-{2-ethyl-4-[5-(5-isobutyl-4-methyl-pyridin-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-amide

https://huagongshe.com/reaction/2037379

반응식

참여 물질

역할이름HCID투입량
반응물Ethanesulfonamide potassium saltHCID 59645266—
반응물(s)-1-{2-Ethyl-4-[5-(5-isobutyl-4-methyl-pyridin-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-3-methylamino-propan-2-olHCID 68629918—
용매DimethylformamideHCID 6228—
생성물Ethanesulfonic acid ((2s)-3-{2-ethyl-4-[5-(5-isobutyl-4-methyl-pyridin-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-amideHCID 44218630—

반응 단계

A solution of the epoxide intermediate of Example 57 (step a, 25 mg, 61 μmol) and ethanesulfonamide potassium salt (27 mg, 184 μmol) in DMF (2 mL) is stirred at 60° C. for 18 h. The solvent is removed in vacuo and the crude product is purified by prep. HPLC to give the title compound (8 mg) as a colourless oil; LC-MS: tR=1.07 min, [M+H]+=517.12.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08575200B2
출처 데이터셋uspto-grants-2013_11
ORD IDord-802634dd8cf04804a5038a1714dbcfb3
출처 메모uspto-grants-2013_11